Cindy Whitehead is CEO of the Pink Ceiling, a cross between a VC firm, a "pinkubator" and a consulting enterprise, where she mentors, invests in, launches and builds other businesses led by or focused on women. Cindy has had a distinguished, 22-year career in health care and started and sold two businesses for more than $1.5 billion. She co-founded and served as CEO for Sprout Pharmaceuticals which, in 2015, broke through with the first FDA-approved drug for low sexual desire in women--dubbed "female Viagra" by the media. She started Sprout only one day after selling another firm that she also co-founded, Slate Pharmaceuticals, which redefined long lasting testosterone treatment for men. Cindy has made waves, and made her own success, in the field of sexual medicine and creating mission driven companies that deliver big. Her results became a business success story featured in major media outlets. Cindy has been an invited speaker at Fortune's Most Powerful Women, the Fast Company Innovation Festival, SXSW and Inc. Women.